{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Cold Steel: Canadian Journal of Surgery Podcast","title":"E61 Masterclass with Michael D'Angelica on Colorectal Liver Metastases","html":"","width":"100%","height":180,"duration":3431,"description":"Dr. Michael D’Angelica (https://twitter.com/MichaelDAngeli2?s=20)is a surgical oncologist and hepatobiliary surgeon at Memorial Sloan Kettering Cancer Centre. He is world-renowned for both his research and clinical expertise in the treatment of colorectal liver metastases. We got to pick his brain on his approach to colorectal liver mets, as well as some of his broader advice for prospective fellows and his experience living in New York City though the COVID19 pandemic.\nTranscript: http://canjsurg.ca/podcast-episode-e61-masterclass-with-michael-dangelica-on-colorectal-liver-metastases/ \nLinks:\n1.\tHepatic resection for colorectal metastases – review by Tim Frankel and Dr. D’Angelica. https://pubmed.ncbi.nlm.nih.gov/24318723/\n2.\tSafety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study. https://pubmed.ncbi.nlm.nih.gov/33095919/\n3.\tThe re-birth of hepatic arterial infusion for colorectal liver metastases by Dr. Nancy Kemeny. https://jgo.amegroups.com/article/view/1042/html\n4.\tAssessing resectability of colorectal liver metastases: How do different subspecialties interpret the same data? https://pubmed.ncbi.nlm.nih.gov/30067183/\n5.\tTreatment sequencing for simultaneous colorectal liver metastases. Review by Dr. D’Angelica. https://pubmed.ncbi.nlm.nih.gov/30816577/\nBio (from AHPBA website):\nDr. D’Angelica is an Assistant Attending in the Department of Surgery, Hepatopancreatobiliary Service at Memorial SloanKettering Cancer Center. He is a Board-certified surgical oncologist with expertise in treating cancer of the liver, bile ducts, gall bladder, and pancreas. He works with a team that has developed and uses many surgical and non-surgical techniques that have shown remarkable success in treating these cancers. Sloan-Kettering’s multi-disciplinary methods of treatment — including novel combinations of surgery, ablation, embolization as well as...","thumbnail_url":"https://img.transistorcdn.com/oyvpQFDz9LsIXBWiTQnBaf-TEq_0jeSP2KI52Z2VDVg/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kZTNh/MWI2MDcwZTcwMGVk/ZjIxM2M4N2VjMWFj/NTdlNS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}